Affinia Therapeutics to Join Key Industry Events
Affinia Therapeutics, a frontrunner in gene therapy innovation, is gearing up to participate in a couple of important investor and industry conferences. These gatherings are a fantastic chance for the company to highlight their progress in developing targeted therapies for both rare and common diseases.
Details on the Upcoming Conferences
Rick Modi, the CEO of Affinia Therapeutics, is slated to engage in meaningful discussions at two significant conferences happening in the coming weeks. These events will facilitate an interactive exchange of ideas about the advancement of innovative gene therapies.
Chardan's 8th Annual Genetic Medicines Conference
This conference will take place from September 30 to October 1 and will feature panel discussions on the engineering of adeno-associated viruses (AAVs). Affinia's involvement will include:
- Format: A panel named 'Engineering of AAVs – The Promise of Next Gen AAVs' along with a corporate presentation.
- Date: September 30.
- Time: The panel starts at 9:30 AM EDT, followed by a presentation at 10:30 AM EDT.
Cell & Gene Meeting on the Mesa
Following this, from October 7 to October 9, Affinia will also take part in the Cell & Gene Meeting on the Mesa. This conference will delve into next-generation gene therapies and will include:
- Format: Corporate presentations as well as a panel focused on enhancing efficiencies in CGT process development.
- Date: October 8.
- Time: The corporate presentation is set for 10:00 AM MST (1:00 PM EDT), followed by a panel at 4:15 PM MST (7:15 PM EDT).
One-on-One Meetings
Alongside the panel discussions, Affinia's management team will be available at both conferences for one-on-one meetings. This presents a wonderful opportunity for more personalized discussions about their cutting-edge approaches in gene therapy.
About Affinia Therapeutics
Affinia Therapeutics is leading the way in rationally designed gene therapies, utilizing a proprietary platform that aims to enhance the effectiveness, safety, and manufacturability of AAV-based treatments. Their pipeline focuses on cardiovascular and neurological conditions, working diligently to improve health outcomes.
Frequently Asked Questions
What does Affinia Therapeutics specialize in?
Affinia Therapeutics is known for its innovative gene therapy solutions that target both rare and common diseases.
Who is at the helm of Affinia Therapeutics?
The company is directed by CEO Rick Modi, who plays an active role in leading health conferences.
What topics will be explored at the upcoming conferences?
The conferences will focus on advancements in gene therapies, specifically looking at improved AAV engineering and next-generation CGT process development.
Where can I find more details about Affinia?
For more information about their undertakings and updates, visit Affinia's official website.
How can I set up one-on-one meetings with Affinia's management?
Those interested in one-on-one meetings can arrange them during the conferences by directly contacting Affinia's management team on-site at the events.
